Tag Archive | "Biogen Idec"

Biogen Idec pharma partners Isis Pharmaceuticals in $320 million neurological disease collaboration

Tags: , , ,


Biogen Idec pharma partners Isis Pharmaceuticals in a broad, multi-year collaboration to leverage antisense technology to advance the treatment of neurological diseases. Read the full story

Adimab expands biotech partnering with Biogen Idec

Tags: , , ,


Adimab announced an expanded biotech partnering with Biogen Idec, a big pharma company,  for the discovery of antibody based therapeutics Read the full story

Biogen Idec and the University of Edinburgh pharma partners for disease treatments

Tags: , ,


Biogen Idec and the University of Edinburgh pharma partners to study multiple sclerosis and motor neuron disease, then identify drug compounds that could potentially be used as treatments Read the full story

Biogen Idec pharma deals Myelin Repair Foundation for novel mouse model

Tags: , , ,


The Myelin Repair Foundation has granted a non-exclusive sublicense to Biogen Idec, as part of their pharma deals, for the use of MRF’s technologies to generate a novel mouse model for all demyelinating diseases, including multiple sclerosis. Read the full story

Biogen Idec big pharma deals Adaptive Biotechnologies for immunological biomarkers collaborative R&D

Tags: , , ,


Adaptive Biotechnologies signed pharma deals with Biogen Idec for the study of the immune repertoire and the search for immunological biomarkers in difficult to treat autoimmune diseases. Read the full story

Biogen Idec: M&A activity 2005-2013

Tags: , ,


Biogen Idec has announced 5 M&A deals since 2005, with the lead deals being the acquisition of Stromedix Read the full story

Biogen Idec: Partnering activity 2005-2013

Tags: , ,


Biogen Idec announced over 70 partnering / licensing deals since 2005, with 13 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology and central nervous system diseases Read the full story

Partnering with Biogen Idec: The importance of alliances and partnerships

Tags: , ,


Biogen Idec is a top pharma/biotech company active in partnering, licensing and M&A in pharmaceuticals and biotechnology Read the full story

Biogen Idec: Company Profile

Tags: , ,


Biogen Idec, a top pharmaceutical/biotech company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Elan restructures Biogen Idec Tysabri partnership

Tags: ,


Tysabri partnership will move from the current 50:50 business collaboration to an upfront payment of $3.25 billion and double digit tiered royalty structure Read the full story